Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Enrolling By InvitationNCT06253507
What this trial is testing

PCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)

Who this might be right for
p47Autosomal RecessiveChronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 10
Early research (Phase 1)Study completedNCT01482377
What this trial is testing

RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin

Who this might be right for
Neoplasms
Hoffmann-La Roche 145
Testing effectiveness (Phase 2)UnknownNCT04648475
What this trial is testing

Safety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma

Who this might be right for
Leukemia, B-cellLymphoma, B-Cell
Chongqing Precision Biotech Co., Ltd 40
Testing effectiveness (Phase 2)Looking for participantsNCT06918912
What this trial is testing

Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure

Who this might be right for
Diffuse Large B-Cell LymphomaHigh-grade B-cell Lymphoma (HGBCL)B-Cell Lymphoma Treatment+1 more
Istituto Clinico Humanitas 50
Testing effectiveness (Phase 2)Looking for participantsNCT06948981
What this trial is testing

GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell Malignancies

Who this might be right for
Hematological Malignancy (Leukemia- Lymphoma)
Grit Biotechnology 46
Very early researchUnknownNCT06532630
What this trial is testing

Anti-CD19-CAR-T Cells in Subjects With Relapsed/Refractory B Cell Malignancies

Who this might be right for
B-Cell Malignancy
Shanghai First Song Biotechnology Co., LTD 9
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT01424982
What this trial is testing

Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete Remission+4 more
M.D. Anderson Cancer Center 88
Testing effectiveness (Phase 2)Looking for participantsNCT05909059
What this trial is testing

CAR T-cell Therapy in Patients With Renal Dysfunction

Who this might be right for
Non-hodgkin Lymphoma,B CellMultiple MyelomaAcute Lymphoblastic Leukemia, Adult
Northside Hospital, Inc. 20
Early research (Phase 1)Study completedNCT03424603
What this trial is testing

Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

Who this might be right for
B-cell LymphomaNon Hodgkin LymphomaMultiple Myeloma+5 more
Sutro Biopharma, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT00193505
What this trial is testing

Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
SCRI Development Innovations, LLC 40
Testing effectiveness (Phase 2)Ended earlyNCT04044560
What this trial is testing

Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaStem Cell LeukemiaMinimal Residual Disease
University of British Columbia 8
Not applicableLooking for participantsNCT06785324
What this trial is testing

Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Philadelphia Chromosome NegativeB Cell Acute Lymphoblastic Leukemia (B-ALL)B-ALL
University of Chicago 20
Not applicableLooking for participantsNCT06821880
What this trial is testing

Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project

Who this might be right for
Chronic Lymphocytic Leukaemia (CLL)Multiple Myeloma (MM)Secondary Immunodeficiency (SID)
Medical University Innsbruck 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT02797470
What this trial is testing

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

Who this might be right for
HIV InfectionMature T-Cell and NK-Cell Non-Hodgkin LymphomaPlasmablastic Lymphoma+8 more
AIDS Malignancy Consortium 11
Testing effectiveness (Phase 2)Study completedNCT00646750
What this trial is testing

Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-cell Difusse Lymphom

Who this might be right for
Non-Hodgkin's Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 31
Not applicableStudy completedNCT06777290
What this trial is testing

Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma

Who this might be right for
Lymphoma, Diffuse Large B-Cell
Charles University, Czech Republic 14
Testing effectiveness (Phase 2)Looking for participantsNCT02877303
What this trial is testing

Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma
M.D. Anderson Cancer Center 80
Early research (Phase 1)UnknownNCT03064269
What this trial is testing

CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia

Who this might be right for
B-cell Acute Lymphocytic Leukemia
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd 10
Testing effectiveness (Phase 2)Ended earlyNCT00006220
What this trial is testing

Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Washington University School of Medicine 5
Next Page